Covered recipient · General Payments record
PAUL BLAKLEY SCADDAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,602.79
- Reported across 178 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $294.34 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $110.56 | 7 |
| ABBVIE INC. | $41.96 | 2 |
| Exact Sciences Corporation | $33.73 | 2 |
| GlaxoSmithKline, LLC. | $30.43 | 2 |
| Otsuka America Pharmaceutical, Inc. | $26.92 | 1 |
| Inspire Medical Systems, Inc. | $19.33 | 1 |
| Lilly USA, LLC | $15.87 | 1 |
| PFIZER INC. | $15.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.94 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106028166 | CMS |
| ABBVIE INC. | $23.02 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106028168 | CMS |
| Exact Sciences Corporation | $13.97 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114877455 | CMS |
| Exact Sciences Corporation | $19.76 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114877460 | CMS |
| GlaxoSmithKline, LLC. | $16.82 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116698153 | CMS |
| GlaxoSmithKline, LLC. | $13.61 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116720342 | CMS |
| Inspire Medical Systems, Inc. | $19.33 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148106878 | CMS |
| Lilly USA, LLC | $15.87 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135283787 | CMS |
| Novo Nordisk Inc | $14.01 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097693017 | CMS |
| Novo Nordisk Inc | $14.68 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096941469 | CMS |
| Novo Nordisk Inc | $15.26 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097449409 | CMS |
| Novo Nordisk Inc | $17.26 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097354741 | CMS |
| Novo Nordisk Inc | $15.62 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097745561 | CMS |
| Novo Nordisk Inc | $15.30 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096843509 | CMS |
| Novo Nordisk Inc | $18.43 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096670470 | CMS |
| Otsuka America Pharmaceutical, Inc. | $26.92 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118976760 | CMS |
| PFIZER INC. | $15.54 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131854135 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.